+772.1%
MRNA vs HRB
+8.0%
+764.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HRB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.9% | -1.2% | -2.0% |
| 7D | -12.7% | -8.0% | -4.7% | -11.5% |
| 30D | -20.7% | -3.8% | -16.9% | -20.3% |
| 3M | +46.3% | -12.5% | +58.7% | +49.7% |
| 6M | +305.2% | +17.9% | +287.3% | +314.2% |
| YTD | +561.2% | +9.2% | +552.1% | +542.3% |
| 1Y | +772.1% | +10.9% | +761.2% | +743.8% |
| All | +772.1% | +8.0% | +764.1% | +743.8% |
Cumulative growth
Daily Returns
Daily percentage return beside HRB.
Daily Out/Under-Performance
Portfolio return minus HRB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HRB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HRB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling